Tempus AI ($TEM) Insider Trading & Smart Money Activity

Tempus AI, Inc. · Health Information Services · Latest filing Oct 12, 2026

Tempus AI, Inc. ($TEM) has 7 insider trades, 1 13F position change and 2 analyst ratings on file. In the last 12 months on the open market, no insider bought and 6 insiders sold ($37.30M), net -$37.30M.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
6
Net insider $ (12 mo)
-$37.30M
Congress trades (12 mo)
0
13F moves on file
1
Analyst ratings on file
2

TEM insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 1 · $147.01K 0 / 0 1 / 0
Q3 2026 0 6 · $37.15M 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All TEM insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Analyst Canaccord Genuity Reiterates to Buy PT $95 Read
Analyst Guggenheim Reiterates to Buy PT $92 -9.4% —
Insider Schoenherr Thomas EdwardCEO, Diagnostics Sell (Open-market sale) 10b5-1 10.28K sh $873.88K -9.9% —
Insider Lefkofsky Eric PCEO and Chairman Sell (Open-market sale) 10b5-1 250K sh $19.37M +7.0% —
Insider Polovin AndrewEVP, Chief Legal Officer Sell (Open-market sale) 10b5-1 2.95K sh $221.32K +2.3% —
Insider Lefkofsky Eric PCEO and Chairman Sell (Open-market sale) 10b5-1 200K sh $16.11M +2.3% —
Insider Bartolucci Ryan MChief Accounting Officer Sell (Open-market sale) 10b5-1 7.06K sh $529.65K +2.3% —
Insider Fukushima RyanCEO, Data Sell (Open-market sale) 10b5-1 700 sh $49K +9.5%-7.5% —
Insider Jennifer Doudna Sell (Open-market sale) 10b5-1 2.67K sh $147.01K +9.8%-21.8% —
13F ARK Investment Management Added +2.05M sh $556.58M -3.0%+5.6% —

1W / 1M / 6M = how TEM moved from the trade or filing date.

Insider trading in TEM: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Schoenherr Thomas Edward CEO, Diagnostics 1 -$873.88K Sep 25, 2026
Lefkofsky Eric P CEO and Chairman 2 -$35.48M Sep 22, 2026
Polovin Andrew EVP, Chief Legal Officer 1 -$221.32K Sep 17, 2026
Bartolucci Ryan M Chief Accounting Officer 1 -$529.65K Sep 17, 2026
Fukushima Ryan CEO, Data 1 -$49K Sep 16, 2026
Jennifer Doudna 1 -$147.01K Jun 25, 2026

Institutions moving TEM (13F)

Analyst ratings on TEM

DateFirmActionRatingPrice target1W1M6MStory
Canaccord Genuity Reiterates Buy $80 → $95 Read
Guggenheim Reiterates Buy $65 → $92 -9.4% —

Frequently asked questions

Are TEM insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 6 insiders made 7 open-market sales worth $37.30M, a net -$37.30M.

What is the latest insider trade in TEM?

Schoenherr Thomas Edward, CEO, Diagnostics filed a sell (open-market sale) of 10.28K sh worth $873.88K on Sep 25, 2026.

Which institutions changed their TEM positions?

Recent 13F filers moving the stock include ARK Investment Management.

Other health information services stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text